FOR PHARMA & BIOTECH ORGANIZATIONS
Medical Affairs is under pressure to demonstrate its value differently.
As the healthcare environment changes, scientific capabilities expand across functions, and expectations of field teams evolve, Medical Affairs leaders are being asked to rethink where the function creates differentiated value—and whether their strategies, structures, and capabilities are keeping pace.
That may require more than developing new skills. It may require rethinking strategy, field models, leadership, roles, and how the organization operates.
Talmedica helps Medical Affairs leaders clarify what is changing, where the underlying challenge sits, and what needs to happen next.
STRATEGIC ADVISORY
When the challenge is bigger than training.
Sometimes the issue isn't a capability gap.
It's the operating model.
The field strategy.
Leadership alignment.
Role clarity.
How teams work across functions.
Or whether the organization is preparing people for what Medical Affairs is becoming.
Talmedica brings an external strategic perspective grounded in more than 20 years across pharmaceutical R&D, Medical Affairs, field leadership, and organizational capability.
THE TALENT CLIFF
Disengagement begins before the restructure.
When professionals sense instability, they disengage proactively — months before any formal action. The cost accumulates. Nothing triggers action.
THE HIDDEN COST
You're already paying for it. You're just not measuring it.
Full salary. Partial output. Months — sometimes years — before anyone acts. Add team drag, manager time and attrition risk. The cost is real. It just doesn't show up on the dashboard.
THE MANAGER PARALYSIS
Managers know. They have no tool to act.
The disengaged employee meets minimum metrics. Can't be formally managed without documentation. So managers work around them — overloading high performers until they leave too.
THE REAL COST
Salary is the obvious cost.
It's not the full one.
A disengaged director at $180–220K running at 40% output represents $90–110K in lost value per year. Multiply that across your current payroll.
Salary Without Output
Full compensation for partial contribution. Every month of disengagement is a month of salary with diminishing return.
Recruiting Cost
External search for a director runs $40–60K in fees — plus onboarding lag — for a role that could have been filled internally.
Team Drag
High performers absorb redistributed work. Over time, they leave — and a disengaged employee costs you your best people too.
Attrition Risk
High performers leave when carrying disengaged colleagues too long. Replacing them costs 1.5–2x their salary.
Missed Market Outcomes
In pharma, disengaged employees sit in critical handoff points between Medical Affairs and Commercial. That gap has market consequences.
Cultural Erosion
Disengagement is visible and contagious. Morale and engagement scores drop — usually before it shows in the data.
If this is already happening in your organization, we should talk.
Not ready to book? Start the conversation
THE SOLUTION
Three outcomes.
All better than doing nothing.
Every engagement produces one of three outcomes. All of them are better than the current default.
OUTCOME ONE
Internal Re-Activation.
The employee finds their Value Anchor — their transferable contribution beneath title and function. They reconnect with where they create impact inside the organization.
OUTCOME TWO
Internal Mobility
The employee identifies where their value fits in a different role or function. You retain the talent and fill an internal gap simultaneously.
OUTCOME THREE
Supported Transition
The employee exits with clarity and a clear narrative. The organization cleans up the payroll cost — before it becomes a performance management or legal problem.
TALMEDICA LLC.
Market alignment. Strategic positioning. A signal the market receives.
FOR ORGANIZATIONS
Workforce Strategy
Talent Transition
Strategic Advisory
©2026. Talmedica LLC. All Rights Reserved.